Latest filing published 06 Sept 2019 for BioRestorative Therapies, Inc., €2,446.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -91.0%Entry US$1,000.00 · Close at T+365 US$90.00
- -88.2%Entry US$1,160.00 · Close at T+365 US$137.20
- -95.3%Entry US$1,039.60 · Close at T+365 US$48.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark Weinreb: trading record in brief
All filings by Mark Weinreb on record concern BioRestorative Therapies, Inc. Over a trading history stretching from 13 December 2011 to 6 September 2019, the count stands at 14 filings.
Purchases make up the whole of the open-market record (12 purchases, €35k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2019 to date brings 11 purchases and no sales.
The median purchase comes to €590. On 11 out of 11 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. For 11 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -85.6%. These figures describe past trades and do not predict future prices.
The newest entry dates from 6 September 2019: an open-market purchase of €1,196, in BioRestorative Therapies, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Weinreb
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.269928.6% of flowCommon StockSEC:0001567619-19-018004:0Canonical exit: 4 Dec 2019 (T+90)
- 5,500 shares@ US$0.2414.0% of flowCommon StockSEC:0001567619-19-018004:1Canonical exit: 5 Dec 2019 (T+90)
- 2,500 shares@ US$0.23656.3% of flowCommon StockSEC:0001567619-19-018004:2Canonical exit: 5 Dec 2019 (T+90)
- 4,000 shares@ US$0.239.8% of flowCommon StockSEC:0001567619-19-018004:3Canonical exit: 5 Dec 2019 (T+90)
- 2,500 shares@ US$0.266.9% of flowCommon StockSEC:0001567619-19-017673:1Canonical exit: 25 Nov 2019 (T+90)
- 2,500 shares@ US$0.2637.0% of flowCommon StockSEC:0001567619-19-017673:2Canonical exit: 27 Nov 2019 (T+90)
- 2,500 shares@ US$0.256.6% of flowCommon StockSEC:0001567619-19-017673:0Canonical exit: 25 Nov 2019 (T+90)
- 2,500 shares@ US$0.277.1% of flowCommon StockSEC:0001567619-19-017673:3Canonical exit: 27 Nov 2019 (T+90)
- 1,700 shares@ US$0.295.2% of flowCommon StockSEC:0001567619-19-017526:0Canonical exit: 20 Nov 2019 (T+90)
- 1,300 shares@ US$0.2613.6% of flowCommon StockSEC:0001567619-19-017526:1Canonical exit: 20 Nov 2019 (T+90)
- 2,000 shares@ US$0.245.1% of flowCommon StockSEC:0001567619-19-017526:2Canonical exit: 20 Nov 2019 (T+90)
- 2,500 sharesCommon StockSEC:0001140361-17-007158:0
- 2,500 sharesCommon StockSEC:0001140361-17-007158:1
- 35,000,000 shares@ US$0.001Common StockSEC:0001140361-11-057260:0Canonical exit: 12 Mar 2012 (T+90)
14 of 14 declarations